Non-squamous Non-Small Cell Lung Cance
Oncology
11 drugs in development·8 companies·1 clinical trial
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| Aybintio (SB8) | Organon & Co. (OGN) |
Phase 3(5)
Phase 2(1)
| Drug | Company |
|---|---|
| tusamitamab ravtansine | Sanofi (SNY) |
Phase 2/Phase 3(3)
Phase 4(1)
Compare drugs
Frequently asked questions
How many drugs are in development for Non-squamous Non-Small Cell Lung Cance?
BioSniper tracks 11 drugs in development for Non-squamous Non-Small Cell Lung Cance across 8 companies.
How many clinical trials target Non-squamous Non-Small Cell Lung Cance?
There are 1 clinical trial targeting Non-squamous Non-Small Cell Lung Cance tracked by BioSniper.
Analyze Organon & Co.'s Non-squamous Non-Small Cell Lung Cance pipeline with AI
Full trial data, competitive analysis, and AI-powered pipeline tracking.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company